News Dermbiont Omar Sebai 6/27/22 Dermbiont Omar Sebai 6/27/22 DermBiont Announces Positive Phase 2 Clinical Trial Data Treating Seborrheic Keratosis Read More Naadam Omar Sebai 11/13/19 Naadam Omar Sebai 11/13/19 Naadam close $16 million Series A Read More
Dermbiont Omar Sebai 6/27/22 Dermbiont Omar Sebai 6/27/22 DermBiont Announces Positive Phase 2 Clinical Trial Data Treating Seborrheic Keratosis Read More
